Cargando…

Differential expression of neuroendocrine markers, TTF-1, p53, and Ki-67 in cervical and pulmonary small cell carcinoma

Small cell carcinoma (SCC) is a highly malignant neuroendocrine tumor that may occur in many anatomic sites of the body. In this study, we compared the different expression of neuroendocrine markers, thyroid transcription factor 1 (TTF-1), p53, and Ki-67 in 23 cases of cervical SCC and 56 cases of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haiping, Zhang, Yan, Chang, Jianfang, Liu, Zhitao, Tang, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078665/ https://www.ncbi.nlm.nih.gov/pubmed/30045295 http://dx.doi.org/10.1097/MD.0000000000011604

Ejemplares similares

Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
por: Patané, Ana Karina, et al.
Publicado: (2021)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
por: Myong, Na-Hye
Publicado: (2003)

Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors
por: Wang, Hai-Yue, et al.
Publicado: (2019)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
por: Fikri, AS Fathinul, et al.
Publicado: (2015)

Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung
por: Liu, Sandy Z, et al.
Publicado: (2014)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015)

Relationship between AgNOR Proteins, Ki-67 Antigen, p53 Immunophenotype and Differentiation Markers in Archival Breast Carcinomas
por: Bànkfalvi, Àgnes, et al.
Publicado: (1998)

The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients
por: Pascale, Mariarosa, et al.
Publicado: (2016)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
por: Vesterinen, Tiina, et al.
Publicado: (2021)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2022)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

Radiomic prediction models for the level of Ki-67 and p53 in glioma
por: Sun, Xiaojun, et al.
Publicado: (2020)

Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas
por: Niculescu, Ştefan Adrian, et al.
Publicado: (2021)

Evaluation of P57, P53 and Ki67 Expression in Meningiomas
por: Küçükosmanoğlu, İlknur, et al.
Publicado: (2022)

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
por: Kim, Bohyun, et al.
Publicado: (2019)

Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis
por: Montebugnoli, L., et al.
Publicado: (2008)

Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer
por: Kim, Hohyun, et al.
Publicado: (2015)

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
por: Yadav, Priyanka, et al.
Publicado: (2019)

Human papillomavirus expression in relation to biological behavior, Ki-67 proliferative marker, and P53 prognostic marker in Schneiderian papilloma
por: Mohsin, Shaymaa Fadhl, et al.
Publicado: (2023)

Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors
por: van Adrichem, R C S, et al.
Publicado: (2013)

ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67
por: Nieveen van Dijkum, Els J. M.
Publicado: (2018)

Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades
por: Simbolo, Michele, et al.
Publicado: (2021)

The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis
por: Naheed, Salma, et al.
Publicado: (2019)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
por: Estaller, Annkathrin, et al.
Publicado: (2022)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Immunohistochemical Evaluation of p53 and Ki67 Expression in Skin Epithelial Tumors
por: Khodaeiani, Effat, et al.
Publicado: (2013)

General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67
por: Sipos, Tamás-Csaba, et al.
Publicado: (2023)

The assessment of Ki-67 for prognosis of gastroenteropancreatic neuroendocrine neoplasm patients: a systematic review and meta-analysis
por: Tao, Zhiwei, et al.
Publicado: (2023)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma
por: Leblebici, Cem, et al.
Publicado: (2017)

The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
por: Popiel-Kopaczyk, Aneta, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

The potential of carcinoembryonic antigen, p53, Ki-67 and glutathion Stransferase-π as clinico-histopathological markers for colorectal cancer()
por: He, Zhenyu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r13md40um7uvot897geku7v8n7